Vitamin E D-α-tocopheryl polyethylene glycol succinate (TPGS) micelles loaded with docetaxel and transferrin have been formulated for brain tumor therapy, as transferrin-conjugated micelles exhibited a high drug loading capacity and remarkable kinetics for drug release that can result in increased and improved drug delivery to the brain when compared to non-targeted formulations [67]. The gene discussed is TF; the disease is brain neoplasm.